Website Links
Description
The information presented on our Site is not intended to provide medical advice or to provide instructions on the use of our products, and should not be relied upon as the basis of any health care decision. This information is not intended to replace informed medical advice from your qualified healthcare provider regarding any questions or concerns you may have about your health or about the potential beneficial uses and possible adverse effects of any health care product.
About InterMune InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases. In pulmonology, the company is focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, irreversible, unpredictable and ultimately fatal lung disease. Pirfenidone is approved for marketing by InterMune in the EU and Canada under the trade name Esbriet®. Pirfenidone is not approved for sale in the United States.
We will retain your information for as long as needed to provide you with requested information and information about upcoming seminars and investor events, to provide you with requested products and services, as necessary to comply with our legal obligations, resolve disputes, and enforce our agreements and for other business purposes or as described to you at the point your information is collected. If you request that we no longer use your information you can contact us at privacy@intermune.com . We will retain and use your information.
This Site may contain certain forward-looking statements about InterMune's financial and operating performance, business plans and prospects, in-line products, and products in development, that involve significant risks and uncertainties. You can identify forward-looking statements by the fact that they contain words such as “anticipate,” “believe,” “estimate,” “expect,” “potential,” “intend,” “project,” or other terms of similar meaning.
Fact sheet
Company contacts
- Daniel G Welch
- CEO
Products & services
Similar companies nearby
-
Poniard Pharmaceuticals
Distance: 1.9 Mi7000 Shoreline CourtSuite 270
94080 South San Francisco -
Sunesis Pharmaceuticals, Inc.
Distance: 2.1 Mi341 Oyster Point Blvd
94080 South San Francisco -
Novacea, Inc.
Distance: 2.5 Mi601 Gateway Boulevard Suite 800 San Francisco
94080 South San Francisco -
Titan Pharmaceuticals, Inc.
Distance: 2.3 Mi400 Oyster Point Blvd Ste 505
94080 South San Francisco -
Catalyst Biosciences
Distance: 3.3 Mi290 Utah Ave
94080 South San Francisco